CDC | Clinical Evaluation and Diagnosis - Severe Acute Respiratory Syndrome (SARS)

Severe Acute Respiratory Syndrome (SARS)

Clinical Evaluation and Diagnosis
May 3, 2005

Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2 (Jan 8, 2004)
In the Absence of SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and Reporting Version 2 (Jan 21, 2004)
Specimen Testing and Diagnosis
- Guidelines for Laboratory Diagnosis of SARS-CoV Infection (Jan 8, 2004)
  Appendix F8, Supplement Fof Public Health Guidance for Community-Level Preparedness and Response to SARS
- Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories (Jan 8, 2004)
  Appendix F3, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS
- Guidelines for Collecting Specimens from Potential SARS Patients (Jan 8, 2004)
  Appendix F4, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS
- Fact Sheet for Clinicians: Interpreting SARS-CoV Test Results from CDC and Other Public Health Laboratories (Jan 8, 2004)
  Appendix F7, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS
Informed Consent for Laboratory Testing

Public: English 800-CDC-INFO Español 888-246-2857 TTY 888-232-6348 Clinician: English 877-554-4625

	Sign up for the Clinician Registry
	Contact Us

				Department of Health and Human Services
	Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A Tel: (404) 639-3311 / Public Inquiries: (800) CDC-INFO